---
title: "Elizabeth Harman — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2a099831-6929-47a9-8ec7-e9616fd73a79
json: https://whiteintel.dev/api/public/dossier/2a099831-6929-47a9-8ec7-e9616fd73a79
identifier: psc:oMP5s7gxrm9c_q9vA4aybjlvBj0
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Elizabeth Harman

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:oMP5s7gxrm9c_q9vA4aybjlvBj0`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2a099831-6929-47a9-8ec7-e9616fd73a79  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2a099831-6929-47a9-8ec7-e9616fd73a79  

## Ownership & control

### Holdings / subsidiaries

- **HARMANPHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f3984040-7fd0-506b-874f-75592e34413f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Elizabeth Harman**. Human view: https://whiteintel.dev/entity/2a099831-6929-47a9-8ec7-e9616fd73a79 · Structured JSON: https://whiteintel.dev/api/public/dossier/2a099831-6929-47a9-8ec7-e9616fd73a79._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._